Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215000 · ClinicalTrials.gov registry record · Phase 4
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
A Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy, sponsored by Morehouse School of Medicine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07215000: Recruiting Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy, sponsored by Morehouse School of Medicine.
NCT07215000 is a Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy that is actively recruiting participants, run by Morehouse School of Medicine. The registered enrollment target is 300 participants, below the 5,867-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215000, a Phase 4 study of Colorectal Cancer Screening and Bowel Cleansing for Colonoscopy, is actively recruiting participants, sponsored by Morehouse School of Medicine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one of the two preparation methods in a 2:1 ratio prior to their scheduled colonoscopy appointments. Surveys will be conducted both before and after the procedures. This project will be conducted over a 12-month period and seeks to compare patient experience of both preparation methods in an outpatient setting. The study will evaluate the rate of preparation completion, patient satisfaction, tolerance of the solutions, and the endoscopic adequacy of each method. Eligible participants are patients aged 18 or older with upcoming colonoscopy appointments who can provide informed consent in English or Spanish. There is no health risks associated with this study, as both bowel preparation methods are FDA-approved and commonly used in clinical practice.
Primary Outcome
Evaluate the patient experience of the two new colon prep options (low volume and tablets) versus conventional bowel prep in an out-patient setting.
Conditions Studied
Interventions
- DRUG Golytely
- DRUG Sulfave
- DRUG Sutab
Study Locations (1)
Georgia
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
What NCT07215000 shows while recruiting
NCT07215000 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 5,867-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 3 interventions - of which Golytely is the first listed.
NCT07215000 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07215000 about?
NCT07215000 is a clinical study titled "Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial". The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one o...
What is the current status of trial NCT07215000?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2025-10-01. Estimated completion is 2027-06.
What conditions does trial NCT07215000 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening, Bowel Cleansing for Colonoscopy.
What interventions are being tested in trial NCT07215000?
The interventions under investigation include: Golytely (DRUG), Sulfave (DRUG), Sutab (DRUG).
Who is sponsoring clinical trial NCT07215000?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215000 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07215000's enrollment target sits among peer trials
300 12th of 19 higher than 8 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
-
CRC Screening in Unscreened Individuals 45-54
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI